1. Home
  2. ALVR vs FMY Comparison

ALVR vs FMY Comparison

Compare ALVR & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • FMY
  • Stock Information
  • Founded
  • ALVR 2013
  • FMY 2005
  • Country
  • ALVR United States
  • FMY United States
  • Employees
  • ALVR N/A
  • FMY N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • FMY Finance/Investors Services
  • Sector
  • ALVR Health Care
  • FMY Finance
  • Exchange
  • ALVR Nasdaq
  • FMY Nasdaq
  • Market Cap
  • ALVR 46.6M
  • FMY 50.4M
  • IPO Year
  • ALVR 2020
  • FMY N/A
  • Fundamental
  • Price
  • ALVR $9.38
  • FMY $11.96
  • Analyst Decision
  • ALVR
  • FMY
  • Analyst Count
  • ALVR 0
  • FMY 0
  • Target Price
  • ALVR N/A
  • FMY N/A
  • AVG Volume (30 Days)
  • ALVR 29.1K
  • FMY 10.1K
  • Earning Date
  • ALVR 03-14-2025
  • FMY 01-01-0001
  • Dividend Yield
  • ALVR N/A
  • FMY 6.98%
  • EPS Growth
  • ALVR N/A
  • FMY N/A
  • EPS
  • ALVR N/A
  • FMY N/A
  • Revenue
  • ALVR N/A
  • FMY N/A
  • Revenue This Year
  • ALVR N/A
  • FMY N/A
  • Revenue Next Year
  • ALVR N/A
  • FMY N/A
  • P/E Ratio
  • ALVR N/A
  • FMY N/A
  • Revenue Growth
  • ALVR N/A
  • FMY N/A
  • 52 Week Low
  • ALVR $7.96
  • FMY $10.71
  • 52 Week High
  • ALVR $24.15
  • FMY $12.17
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 39.33
  • FMY 51.52
  • Support Level
  • ALVR $7.96
  • FMY $11.87
  • Resistance Level
  • ALVR $10.00
  • FMY $11.78
  • Average True Range (ATR)
  • ALVR 1.14
  • FMY 0.15
  • MACD
  • ALVR 0.03
  • FMY 0.02
  • Stochastic Oscillator
  • ALVR 35.50
  • FMY 93.18

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

Share on Social Networks: